254 employees
Geron is a biotechnology company that specializes in developing blood cancer treatments for hematologic malignancies.
1992
$125M
from 2 investors over 2 rounds
Geron raised $125M on June 30, 2022
Investors: Hercules Capital, Inc.
Geron raised undisclosed on January 1, 1992
Investors: Venrock